Pricing

Log inSign up

Atalanta Therapeutics

52 people · 0 jobs
‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Morgan Molloy
Chief Corporate Development Officer
Craig Mello
Co-founder
Jeff Young
Chief Financial Officer
Serena Hung
Chief Medical Officer
Antonio N.
Sr. Director Information Technology
Garth Kinberger
VP, Chemistry
Stefan McDonough
VP & Head, Neuroscience
Mingwei Li
Scientific Technical Leader I
Guillermo Yudowski
VP, Biochemistry & Pharmacology, In vitro Biology
QC
Qingmin Chen
Vice President, Head Of In Vivo Pharmacology

Board & advisors

Neil Aronin
Co-founder & Scientific Advisor
Anastasia Khvorova
Co-founder & Scientific Advisor
Craig Mello
Co-founder & Scientific Advisor
Jim Glasheen
Co-founder
Michael Berman
Director
T. Scott Johnson
Director
Stephen Knight
Director
Stacie Weninger
Director
Alfred W. Sandrock
Director

Similar companies

Cellares

5 followers

Tango Therapeutics

3 followers

Dyno Therapeutics

4 followers

Odyssey Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

GRAIL

30 followers

Explore companies